[Commentary on the article of A. Pruss and R. von Versen: Influence of European regulations on quality, safety and availability of cell and tissue allografts in Germany].
Middeler
G
G
Dr. Middeler et al. GmbH-DiapharmGruppe, Maria-Goeppert-Strasse 1, 23562 Lübeck. guido.middeler@diapharmgruppe.de
Machens
H-G
HG
D018586:Bone Banks / Q000331:legislation & jurisprudence / Q000592:standards; D002102:Cadaver; D017690:Cell Transplantation / Q000331:legislation & jurisprudence* / Q000592:standards; D005858:Germany; D006801:Humans; D007880:Legislation, Drug; D004364:Pharmaceutical Preparations; D011787:Quality of Health Care; D016038:Skin Transplantation / Q000331:legislation & jurisprudence / Q000592:standards; D014015:Tissue Banks / Q000331:legislation & jurisprudence* / Q000592:standards; D014019:Tissue Donors; D016378:Tissue Transplantation / Q000331:legislation & jurisprudence* / Q000592:standards
D004364:Pharmaceutical Preparations